摘要
肺鳞癌伴心脏侵犯是一种极罕见的恶性肿瘤,死亡率较高,临床上缺乏特异性、易漏诊、误诊。本文报道了晚期肺鳞癌伴心脏侵犯一例,患者经免疫治疗联合化疗后,预后良好,无不良事件发生,证明此方案安全有效。现报道其诊治经过,以供临床参考。
Squamous lung cancer with cardiac invasion is an extremely rare malignancy with a high mortality rate,which is clinically low in specificity and easily missed and misdiagnosed.This paper report a case of advanced squamous lung cancer with cardiac invasion.After immunotherapy combined with chemotherapy,the patient had a good prognosis and no adverse events,which proved that this regimen was safe and effective.The diagnosis and treatment of this case are reported for clinical reference.
作者
曾驿乔
邵锦虹
蔡兴东
刘升明
ZENG Yi-Jiao;SHAO Jin-hong;CAI Xing-dong;LIU Sheng-ming(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Jinan University,Guangzhou 510630,Guangdong,CHINA)
出处
《海南医学》
CAS
2023年第18期2720-2722,共3页
Hainan Medical Journal
关键词
肺鳞状细胞癌
心脏侵犯
免疫检查点抑制剂
化疗
疗效
Lung squamous cell carcinoma
Cardiac invasion
Immune checkpoint inhibitors
Chemotherapy
Efficacy